Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication January 15, 2013
- Accepted for publication May 13, 2013
- Published online November 1, 2013.
Article Versions
- previous version (September 12, 2013 - 09:05).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2013 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
Author Information
- Nerissa Therese Viola-Villegas1,2,
- Samuel L. Rice1,2,
- Sean Carlin1,2,
- Xiaohong Wu3,
- Michael J. Evans4,
- Kuntal K. Sevak1,2,
- Marija Drobjnak5,
- Govind Ragupathi3,
- Ritsuko Sawada6,
- Wolfgang W. Scholz6,
- Philip O. Livingston6 and
- Jason S. Lewis1,2
- 1Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York, New York
- 2Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York
- 3Laboratory of Tumor Vaccinology, Melanoma and Sarcoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York
- 4Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York
- 5Pathology Core Facility, Memorial Sloan-Kettering Cancer Center, New York, New York; and
- 6Mabvax, San Diego, California
- For correspondence or reprints contact: Jason S. Lewis, Radiochemistry and Imaging Sciences Service, Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10065. E-mail: lewisj2{at}mskcc.org
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Development of a MUC16-Targeted Near-Infrared Fluorescent Antibody Conjugate for Intraoperative Imaging of Pancreatic Cancer
- Retooling a Blood-Based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic Cancer
- Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine
- The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice
- Leveraging Bioorthogonal Click Chemistry to Improve 225Ac-Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma
- A PET Imaging Strategy for Interrogating Target Engagement and Oncogene Status in Pancreatic Cancer
- IFN{gamma} PET Imaging as a Predictive Tool for Monitoring Response to Tumor Immunotherapy
- Establishment of the In Vivo Efficacy of Pretargeted Radioimmunotherapy Utilizing Inverse Electron Demand Diels-Alder Click Chemistry
- Microfluidic Preparation of a 89Zr-Labeled Trastuzumab Single-Patient Dose
- Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation Doses
- Pretargeted Immuno-PET: Overcoming Limitations of Space and Time
- Antagonism of EGFR and HER3 Enhances the Response to Inhibitors of the PI3K-Akt Pathway in Triple-Negative Breast Cancer